Your session is about to expire
← Back to Search
CONSULT-BP Training for High Blood Pressure (CONSULT-BP Trial)
N/A
Waitlist Available
Led By Jennifer Tjia, MD, MSCE
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months after the intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether a training intervention can help early-stage healthcare providers communicate better with patients and improve patients' blood pressure levels.
Who is the study for?
This trial is for early-stage healthcare providers who haven't done the CONSULT-BP training and work where they can track patient data. It's also for English-speaking patients who are non-White or on Medicaid with high blood pressure recorded in their medical records. First-year trainees, pregnant women, and patients with certain mental health conditions or serious illnesses that affect self-care are excluded.
What is being tested?
The CONSULT-BP study tests an educational program aimed at improving healthcare providers' communication skills, reducing bias, and building better relationships with patients to help manage high blood pressure more effectively. The hypothesis is that this training will result in lower blood pressure levels in patients compared to before the providers received the training.
What are the potential side effects?
Since this intervention involves education and skill development rather than medication or medical procedures, there aren't typical side effects like those associated with drugs or surgery. However, participants may experience stress or discomfort during role-playing exercises as part of the training.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 months after the intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months after the intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Blood pressure
Secondary study objectives
Blood Pressure Self Care Scale
Patient Reported Trust in Heathcare Provider
Quality of Communication
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
5Treatment groups
Experimental Treatment
Group I: Healthcare Trainees - Cluster 5Experimental Treatment1 Intervention
Within each academic year, trainee clusters are randomized to 1 of 5 start date training times for Other: CONSULT-BP Educational Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period.
Group II: Healthcare Trainees - Cluster 4Experimental Treatment1 Intervention
Within each academic year, trainee clusters are randomized to 1 of 5 start date training times for Other: CONSULT-BP Educational Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period.
Group III: Healthcare Trainees - Cluster 3Experimental Treatment1 Intervention
Within each academic year, trainee clusters are randomized to 1 of 5 start date training times for Other: CONSULT-BP Educational Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period.
Group IV: Healthcare Trainees - Cluster 2Experimental Treatment1 Intervention
Within each academic year, trainee clusters are randomized to 1 of 5 start date training times for Other: CONSULT-BP Educational Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period.
Group V: Healthcare Trainees - Cluster 1Experimental Treatment1 Intervention
Within each academic year, trainee clusters are randomized to 1 of 5 start date training times for Other: CONSULT-BP Educational Intervention. Each arm has a pre-intervention (control) period and a post-intervention (exposure) period.
Find a Location
Who is running the clinical trial?
University of Massachusetts, WorcesterLead Sponsor
362 Previous Clinical Trials
992,841 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
438 Previous Clinical Trials
1,379,201 Total Patients Enrolled
Jennifer Tjia, MD, MSCEPrincipal Investigator - UMass Medical School
University of Massachusetts, Worcester
2 Previous Clinical Trials
105 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently receiving end-of-life care in a hospice.People with schizophrenia are not allowed to participate.You have another serious health condition that would make it hard for you to control your high blood pressure on your own.You are not of a non-White racial/ethnic background or do not have Medicaid.You have been diagnosed with high blood pressure and it is recorded in your electronic medical records.
Research Study Groups:
This trial has the following groups:- Group 1: Healthcare Trainees - Cluster 1
- Group 2: Healthcare Trainees - Cluster 2
- Group 3: Healthcare Trainees - Cluster 3
- Group 4: Healthcare Trainees - Cluster 4
- Group 5: Healthcare Trainees - Cluster 5
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.